Cyrona Cell uses Wharton’s Jelly mesenchymal cells that have been derived from infant umbilical cords as they can:

As type 1 diabetes is an autoimmune disease, the aim of cell therapy is to preserve what pancreatic β-cell function remains, repair and regenerate areas of damage, and to prevent the immune system from targeting the remaining β-cells in order to enable the body to resume regulating blood sugar levels and heal.
Scientifically-Proven Results
|
Year |
University/Centre |
Cohort Size |
Study Duration |
Results |
|---|---|---|---|---|
|
2013 |
Qingdao University, China |
29 |
21 months |
Significantly improved blood sugar levels |
|
2016 |
University of Miami, US, and Xiamen University, China |
21 |
12 months |
105.7% increase in C-peptide levels, 49.3% increase in insulin production, 12.6% decrease in HbA1c readings, 24.4% decrease in fasting blood sugar levels, and 29.9% lower reliance on daily diabetes injections and medications |
|
2017 |
National Yang Ming University, China |
Improved C-peptide, insulin levels and glucose tolerance |
||
|
2018 |
University of Perugia, Italy |
216 days |
Full and sustained hyperglycaemic remission |
Achieving high standards in our work is of paramount importance to us. As such, we only produce and use premium grade passage 1 (P1) and passage 2 (P2) Wharton’s Jelly mesenchymal stem cells (wjMSCs) in all our therapy programmes. These cellular products have also been thoroughly screened and analyzed in accordance with the requirements of The International Society for Cellular Therapy prior to use.
We also use the latest in cellular research and technologies to tailor our therapy programmes according to the needs of the individual. Furthermore, our microbiology and clinical team as well as our extensively experienced board-certified physicians are geared towards your safety and wellbeing.
All our therapy programmes are conducted using premium grade P1 and P2 wjMSCs and by board-certified experienced specialists. All patients are also provided with pre-transfusion analysis reports of any and all cellular and supplementary products used during treatment.
International patients will be provided with airport transfer services and accommodations as well as in-city transportation to and from every therapy session.
As no two people are alike, our specialists review each patient’s medical reports before developing the best treatment protocol to address their unique needs. Therefore, before speaking to one of our Customer Service Representatives, it is best to have the following handy:
Download our eBook and receive our weekly in-depth and exclusive newsletter about Type 1 Diabetes.